National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Guselkumab (Tremfya®) for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy.

 

NCPE Assessment Process Complete
Rapid review commissioned 01/12/2017
Rapid review completed 06/02/2018
Rapid Review outcome Full pharmacoeconomic assessment recommended at the submitted price